Is Mounjaro (tirzepatide) approved for weight loss?

No, Mounjaro® is not FDA-approved for weight loss. Currently, it is FDA-approved for the treatment of type 2 diabetes. You may have heard of Mounjaro being used for weight loss, and in that case it is considered off-label use because it is being used for a non-FDA-approved indication. The active ingredient of Mounjaro, tirzepatide, is also the same active ingredient as Zepbound® which has recently been FDA-approved for weight loss treatment. Both medications have shown promising weight loss benefits and are administered at the same incremental dosing levels. It should be noted that medications for weight loss may be indicated for individuals with a body mass index (BMI) of 27+ kg/m2 with a weight related medication condition such as high blood pressure or diabetes or a BMI of 30+ kg/m2.

‍

Some people choose to get compounded semaglutide medication instead of the brand name medication like Mounjaro. Although they are often available at a lower cost, it’s important to know that these compounded weight loss medications come with real risks. The molecule has not been tested in clinical trials and approved by the FDA for safety and efficacy. Additionally, compounding facilities may not be FDA monitored and there is a risk of contaminants and patient dosing errors. Form is dedicated to providing quality evidence-based medical weight loss care. The National Obesity Medicine Association recently published an extensive position statement advising against using compounded peptides that also highlights the risk to individuals. Form Health is aligned with the Obesity Medicine Association’s position. We do not prescribe compounded medication.